Suchergebnisse - (Subject:"Tocilizumab")

PubPharm (16)

1

The key data from the 2022 European Thyroid Association congress : Toward personalized treatment of Graves' orbitopathy

enthalten in: Annales d'endocrinologie | 2023

von Abeillon-du Payrat, J. | Caron, P.

2

Comment on : Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis by Humby et al

enthalten in: Clinical and experimental rheumatology | 2023

von Duran, E. | Yildirim, B. | Karadağ, �.

CommentOn: Lancet. 2021 Jan 23;397(10271):305-317. - PMID 33485455

3

Re-evaluation of rituximab therapy for idiopathic Castleman disease : Retrospective study from single-center experience

enthalten in: European journal of haematology | 2022

von Ide, M. | Ohnishi, H. | Fukumoto, T. | +2

4

Tocilizumab and rituximab for anti-MDA-5 positive amyopathic dermatomyositis complicated with macrophage activation syndrome and progressive fibrosing interstitial lung disease

enthalten in: Scandinavian journal of rheumatology | 2022

von Su, C. | Liao, H. | Tsai, C.

5

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides : a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

enthalten in: Annals of the rheumatic diseases | 2022

von Felten, R. | Duret, P. | Bauer, E. | +26

6

Should tocilizumab be the first line treatment for neuromyelitis optica together with rituximab?

enthalten in: Neurologia | 2021

von Sawaya, R. | Saab, G. | Moussa, H.

7

A pediatric case of tocilizumab-resistant TAFRO syndrome treated successfully with rituximab

enthalten in: Pediatric blood & cancer | 2020

von Minamikawa, S. | Matsumura, O. | Sato, S. | +2

8

Allogenic hematopoietic stem cell transplantation for prolonged bone marrow aplasia after chimeric antigen receptor (CAR) T-cell therapy for relapsed diffuse large B-cell lymphoma

enthalten in: American journal of hematology | 2020

von Qasrawi, A. | Arora, R. | Ramlal, R. | +2

9

Comment on : Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from a nationwide Swedish register

enthalten in: Rheumatology (Oxford, England) | 2019

von Weil, A.

CommentOn: Rheumatology (Oxford). 2019 Jan 21;:null. - PMID 30668875

10

Comment on : Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply

enthalten in: Rheumatology (Oxford, England) | 2019

von Frisell, T. | Askling, J.

CommentOn: Rheumatology (Oxford). 2019 Jan 21;:null. - PMID 30668875